EYPT
Eyepoint Pharmaceuticals Inc
3.30$
+0.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.6% | +170.5% | +19.5% | +12.7% | +14.5% | +6.4% | +8.2% | +7.1% | +21.2% | -8.9% | +8.5% | – | |
| – | -1.1% | +253.7% | -31.5% | -14.4% | +6.1% | -1.0% | -12.1% | -6.5% | +5.0% | +72.4% | -10.7% | – | |
| – | – | – | – | -576.5% | – | – | – | – | – | – | – | – | |
| – | -48.7% | +35.2% | -24.6% | +74.9% | -75.6% | -28.1% | +342.0% | -34.6% | +23.6% | +1.1% | +20.4% | – | |
| – | +2,641.2% | – | -870.9% | – | -692.5% | – | +22.3% | +14.6% | -234.8% | – | +27.2% | – | |
| – | – | – | -98.2% | +0.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -56.2% | +9.4% | -54.3% | +68.8% | +0.0% | +7.4% | -3.4% | – | |
| – | +2,008.5% | -99.9% | +186.1% | +3,514.9% | +1,175.4% | -100.6% | – | +3,010.5% | +2,155.3% | -101.6% | – | – | |
| – | – | -106.9% | – | – | – | -173.2% | – | – | +693.4% | -188.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.